Pharmaceutical Industry Growth in India (CAGR of 13.01%) | Research Report 2023-2028

PRESS RELEASE

Published February 7, 2023

Industry Overview:

A pharmaceutical refers to a drug that is used for the treatment of different forms of illness, such as flu, cardiovascular disease, sexually transmitted diseases (STDs), diabetes, Parkinson's disease, and cancer. It aims to provide medical care to patients according to their characteristics and genetic makeup. It helps in enhancing the well-being of individuals and managing symptoms efficiently as compared to traditional methods. It is widely sold in the form of prescription drugs, including branded, generic and over counter drugs. There has been a considerable rise in the sales of pharmaceuticals across India due to the easy availability of numerous pharmaceuticals.

Get a Free Sample Copy of Report at – https://www.imarcgroup.com/india-pharmaceutical-market/requestsample

Industry Growth:

The India pharmaceutical market is expected to exhibit a growth rate (CAGR) of 13.01% during 2023-2028. The increasing prevalence of chronic disorders among the masses is driving the market in India. Moreover, the growing demand for pharmaceuticals during the coronavirus disease (COVID-19) in India to provide adequate medications and care to patients is also contributing to the market. Furthermore, the increasing investments by the government to support rapid drug discovery for improving health outcomes are providing a thrust to the demand for pharmaceuticals. In line with this, numerous major companies are developing specialty pharmaceutical drugs, such as novel biologics and biosimilars, complex generics, and preventive medication, this is creating a positive market outlook. Additionally, the increasing investments in long-term and high-risk projects by various funding agencies are further strengthening the market.

Do you know more information, Contact to our analyst at- https://www.imarcgroup.com/india-pharmaceutical-market

The emergence of new technologies, including the widespread implementation of robotics and artificial intelligence (AI) to diagnose and manage diseases, are acting as growth-inducing factors. Furthermore, continuous improvements in medical infrastructure and extensive research and development (R&D) activities conducted by leading players to manufacture novel pharmaceuticals are major driving factors. Besides this, constant developments in the single-window system to streamline the drug development process and facilitate fast approvals of commercially viable projects are catalyzing the sales of pharmaceuticals across the country. Other factors, such as the rising geriatric population and the development of medical settings in rural and geographically extended location, are also influencing the market across India.

India Pharmaceutical Market 2023-2028 Analysis and Segmentation:

Breakup by Type:

Pharmaceutical Drugs

Cardiovascular Drugs
Dermatology Drugs
Gastrointestinal Drugs
Genito-Urinary Drugs
Hematology Drugs
Anti-Infective Drugs
Metabolic Disorder Drugs
Musculoskeletal Disorder Drugs
Central Nervous System Drugs
Oncology Drugs
Ophthalmology Drugs
Respiratory Diseases Drugs

Biologics

Monoclonal Antibodies (MAbS)
Therapeutic Proteins
Vaccines

Breakup by Nature:

Organic
Conventional

Breakup by Region:

North India
West and Central India
South India
East India

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Highlights of the Report:

Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800